Clinical approach to genetic cardiomyopathy in children

Marcy L. Schwartz, Gerald F. Cox, Angela E. Lin, Mark S. Korson, Antonio Perez-Atayde, Ronald V. Lacro, Steven E Lipshultz

Research output: Contribution to journalArticle

115 Citations (Scopus)

Abstract

Background: Cardiomyopathy (CM) remains one of the leading cardiac causes of death in children, although in the majority of cases, the cause is unknown. To have an impact on morbidity and mortality, attention must shift to etiology-specific treatments. The diagnostic evaluation of children with CM of genetic origin is complicated by the large number of rare genetic causes, the broad range of clinical presentations, and the array of specialized diagnostic tests and biochemical. Methods and Results: We present a multidisciplinary diagnostic approach to pediatric CM of genetic etiology. We specify criteria for abnormal left ventricular systolic performance and structure that suggest CM based on established normal echocardiographic measurements and list other indications to consider an evaluation for CM. We provide a differential diagnosis of genetic conditions associated with CM, classified as inborn errors of metabolism, malformation syndromes, neuromuscular diseases, and familial isolated CM disorders. A diagnostic strategy is offered that is based on the clinical presentation; biochemical abnormalities, encephalopathy, dysmorphic features or multiple malformations, neuromuscular disease, apparently isolated CM, and pathological specimen findings. Adjunctive treatment measures are recommended for severely ill patients in whom a metabolic cause of CM is suspected. A protocol is provided for the evaluation of moribund patients. Conclusions. In summary, we hope to assist pediatric cardiologists and other subspecialists in the evaluation of children with CM for a possible genetic cause using a presentation-based- approach. This should increase the percentage of children with CM for whom a diagnosis can be established, with important implications for treatment, prognosis, and genetic counseling.

Original languageEnglish
Pages (from-to)2021-2038
Number of pages18
JournalCirculation
Volume94
Issue number8
StatePublished - Oct 30 1996
Externally publishedYes

Fingerprint

Cardiomyopathies
Neuromuscular Diseases
Pediatrics
Inborn Errors Metabolism
Genetic Counseling
Brain Diseases
Routine Diagnostic Tests
Cause of Death
Differential Diagnosis
Therapeutics
Morbidity
Mortality

Keywords

  • cardiomyopathy
  • diagnosis
  • genetics

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Schwartz, M. L., Cox, G. F., Lin, A. E., Korson, M. S., Perez-Atayde, A., Lacro, R. V., & Lipshultz, S. E. (1996). Clinical approach to genetic cardiomyopathy in children. Circulation, 94(8), 2021-2038.

Clinical approach to genetic cardiomyopathy in children. / Schwartz, Marcy L.; Cox, Gerald F.; Lin, Angela E.; Korson, Mark S.; Perez-Atayde, Antonio; Lacro, Ronald V.; Lipshultz, Steven E.

In: Circulation, Vol. 94, No. 8, 30.10.1996, p. 2021-2038.

Research output: Contribution to journalArticle

Schwartz, ML, Cox, GF, Lin, AE, Korson, MS, Perez-Atayde, A, Lacro, RV & Lipshultz, SE 1996, 'Clinical approach to genetic cardiomyopathy in children', Circulation, vol. 94, no. 8, pp. 2021-2038.
Schwartz ML, Cox GF, Lin AE, Korson MS, Perez-Atayde A, Lacro RV et al. Clinical approach to genetic cardiomyopathy in children. Circulation. 1996 Oct 30;94(8):2021-2038.
Schwartz, Marcy L. ; Cox, Gerald F. ; Lin, Angela E. ; Korson, Mark S. ; Perez-Atayde, Antonio ; Lacro, Ronald V. ; Lipshultz, Steven E. / Clinical approach to genetic cardiomyopathy in children. In: Circulation. 1996 ; Vol. 94, No. 8. pp. 2021-2038.
@article{6bbdd31b8336409c98dfa42facb14342,
title = "Clinical approach to genetic cardiomyopathy in children",
abstract = "Background: Cardiomyopathy (CM) remains one of the leading cardiac causes of death in children, although in the majority of cases, the cause is unknown. To have an impact on morbidity and mortality, attention must shift to etiology-specific treatments. The diagnostic evaluation of children with CM of genetic origin is complicated by the large number of rare genetic causes, the broad range of clinical presentations, and the array of specialized diagnostic tests and biochemical. Methods and Results: We present a multidisciplinary diagnostic approach to pediatric CM of genetic etiology. We specify criteria for abnormal left ventricular systolic performance and structure that suggest CM based on established normal echocardiographic measurements and list other indications to consider an evaluation for CM. We provide a differential diagnosis of genetic conditions associated with CM, classified as inborn errors of metabolism, malformation syndromes, neuromuscular diseases, and familial isolated CM disorders. A diagnostic strategy is offered that is based on the clinical presentation; biochemical abnormalities, encephalopathy, dysmorphic features or multiple malformations, neuromuscular disease, apparently isolated CM, and pathological specimen findings. Adjunctive treatment measures are recommended for severely ill patients in whom a metabolic cause of CM is suspected. A protocol is provided for the evaluation of moribund patients. Conclusions. In summary, we hope to assist pediatric cardiologists and other subspecialists in the evaluation of children with CM for a possible genetic cause using a presentation-based- approach. This should increase the percentage of children with CM for whom a diagnosis can be established, with important implications for treatment, prognosis, and genetic counseling.",
keywords = "cardiomyopathy, diagnosis, genetics",
author = "Schwartz, {Marcy L.} and Cox, {Gerald F.} and Lin, {Angela E.} and Korson, {Mark S.} and Antonio Perez-Atayde and Lacro, {Ronald V.} and Lipshultz, {Steven E}",
year = "1996",
month = "10",
day = "30",
language = "English",
volume = "94",
pages = "2021--2038",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Clinical approach to genetic cardiomyopathy in children

AU - Schwartz, Marcy L.

AU - Cox, Gerald F.

AU - Lin, Angela E.

AU - Korson, Mark S.

AU - Perez-Atayde, Antonio

AU - Lacro, Ronald V.

AU - Lipshultz, Steven E

PY - 1996/10/30

Y1 - 1996/10/30

N2 - Background: Cardiomyopathy (CM) remains one of the leading cardiac causes of death in children, although in the majority of cases, the cause is unknown. To have an impact on morbidity and mortality, attention must shift to etiology-specific treatments. The diagnostic evaluation of children with CM of genetic origin is complicated by the large number of rare genetic causes, the broad range of clinical presentations, and the array of specialized diagnostic tests and biochemical. Methods and Results: We present a multidisciplinary diagnostic approach to pediatric CM of genetic etiology. We specify criteria for abnormal left ventricular systolic performance and structure that suggest CM based on established normal echocardiographic measurements and list other indications to consider an evaluation for CM. We provide a differential diagnosis of genetic conditions associated with CM, classified as inborn errors of metabolism, malformation syndromes, neuromuscular diseases, and familial isolated CM disorders. A diagnostic strategy is offered that is based on the clinical presentation; biochemical abnormalities, encephalopathy, dysmorphic features or multiple malformations, neuromuscular disease, apparently isolated CM, and pathological specimen findings. Adjunctive treatment measures are recommended for severely ill patients in whom a metabolic cause of CM is suspected. A protocol is provided for the evaluation of moribund patients. Conclusions. In summary, we hope to assist pediatric cardiologists and other subspecialists in the evaluation of children with CM for a possible genetic cause using a presentation-based- approach. This should increase the percentage of children with CM for whom a diagnosis can be established, with important implications for treatment, prognosis, and genetic counseling.

AB - Background: Cardiomyopathy (CM) remains one of the leading cardiac causes of death in children, although in the majority of cases, the cause is unknown. To have an impact on morbidity and mortality, attention must shift to etiology-specific treatments. The diagnostic evaluation of children with CM of genetic origin is complicated by the large number of rare genetic causes, the broad range of clinical presentations, and the array of specialized diagnostic tests and biochemical. Methods and Results: We present a multidisciplinary diagnostic approach to pediatric CM of genetic etiology. We specify criteria for abnormal left ventricular systolic performance and structure that suggest CM based on established normal echocardiographic measurements and list other indications to consider an evaluation for CM. We provide a differential diagnosis of genetic conditions associated with CM, classified as inborn errors of metabolism, malformation syndromes, neuromuscular diseases, and familial isolated CM disorders. A diagnostic strategy is offered that is based on the clinical presentation; biochemical abnormalities, encephalopathy, dysmorphic features or multiple malformations, neuromuscular disease, apparently isolated CM, and pathological specimen findings. Adjunctive treatment measures are recommended for severely ill patients in whom a metabolic cause of CM is suspected. A protocol is provided for the evaluation of moribund patients. Conclusions. In summary, we hope to assist pediatric cardiologists and other subspecialists in the evaluation of children with CM for a possible genetic cause using a presentation-based- approach. This should increase the percentage of children with CM for whom a diagnosis can be established, with important implications for treatment, prognosis, and genetic counseling.

KW - cardiomyopathy

KW - diagnosis

KW - genetics

UR - http://www.scopus.com/inward/record.url?scp=0029838265&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029838265&partnerID=8YFLogxK

M3 - Article

VL - 94

SP - 2021

EP - 2038

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 8

ER -